Targeted therapies: Afatinib-new therapy option for EGFR-mutant lung cancer Journal Article
| Authors: | Yu, H. A.; Pao, W. |
| Article Title: | Targeted therapies: Afatinib-new therapy option for EGFR-mutant lung cancer |
| Keywords: | cancer survival; exon; gene deletion; mutation; fatigue; cisplatin; erlotinib; placebo; cancer combination chemotherapy; diarrhea; dose response; drug dose reduction; drug efficacy; drug safety; drug withdrawal; side effect; treatment planning; unspecified side effect; drug approval; gemcitabine; antineoplastic agent; metastasis; progression free survival; lung non small cell cancer; mucosa inflammation; nausea; carcinoma, non-small-cell lung; lung neoplasms; epidermal growth factor receptor; lung cancer; receptor, epidermal growth factor; drug potency; substitution reaction; cetuximab; protein tyrosine kinase inhibitor; coughing; dyspnea; rash; drug cost; dysphagia; lung adenocarcinoma; gefitinib; nail; short survey; clinical effectiveness; large cell carcinoma; lung squamous cell carcinoma; platinum complex; egfr gene; dry skin; quinazolines; pemetrexed; mouth pain; drug indication; molecular targeted therapy; afatinib; humans; human; priority journal |
| Journal Title: | Nature Reviews Clinical Oncology |
| Volume: | 10 |
| Issue: | 10 |
| ISSN: | 1759-4774 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2013-10-01 |
| Start Page: | 551 |
| End Page: | 552 |
| Language: | English |
| DOI: | 10.1038/nrclinonc.2013.154 |
| PUBMED: | 23959269 |
| PROVIDER: | scopus |
| PMCID: | PMC4665630 |
| DOI/URL: | |
| Notes: | Export Date: 9 May 2014 -- Source: Scopus |
